IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
Recruiting now · Not applicable
Conditions studied: Wound Heal, Ulcer
In brief
A multi-center, prospective, observer-blinded, randomized controlled clinical trial to evaluate the efficacy of PPECM augmented standard of care versus standard of care alone in the management of hard-to-heal diabetic foot ulcers.
Key facts
- Study ID
- NCT06616844
- Run by
- ConvaTec Inc.
- People needed
- 194
- Starts
- 2025-02-12
- Expected to finish
- 2026-07-01
- Last updated by the study team
- 2025-05-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- US-FAS — Raleigh, North Carolina, United States (enrolling)
- Center for Clinical Research — San Francisco, California, United States (enrolling)
- ILD Research Center — Vista, California, United States (enrolling)
- Northwell Health Comprehensive Wound Healing Center — New Hyde Park, New York, United States (enrolling)
- Angel City Research — Los Angeles, California, United States (enrolling)
- Indiana Foot & Ankle — Jasper, Indiana, United States (enrolling)
- US-FAS — Hagerstown, Maryland, United States (enrolling)
- Dinamo Research and Diagnostic Center — Hialeah, Florida, United States
- Boston Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.